Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 6:4:137.
doi: 10.3389/fonc.2014.00137. eCollection 2014.

Tumor-associated macrophages contribute to tumor progression in ovarian cancer

Affiliations
Review

Tumor-associated macrophages contribute to tumor progression in ovarian cancer

Emily K Colvin. Front Oncol. .

Abstract

Ovarian cancer is the leading cause of death in women with gynecological malignancy and improvements in current treatments are needed. As with many other solid cancers, the ovarian tumor microenvironment is emerging as a key player in tumor progression and a potential therapeutic target. The tumor microenvironment contains several non-malignant cell types that are known to contribute to tumor progression and metastasis. Included in this population of non-malignant cells are several different types of immune cells, of which tumor-associated macrophages (TAMs) are the most abundant. An increasing amount of evidence is emerging to suggest that TAMs display a unique activation profile in ovarian tumors and are able to create an immunosuppressive microenvironment, allowing tumors to evade immune detection and promoting tumor progression. Therefore, an increased understanding of how these immune cells interact with tumor cells and the microenvironment will greatly benefit the development of more effective immunotherapies to treat ovarian cancer. This review focuses on the role of TAMs in the ovarian tumor microenvironment and how they promote tumor progression.

Keywords: macrophages in ovarian cancer; ovarian cancer; tumor microenvironment; tumor-associated macrophages.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ovarian cancer cells produce multiple factors to recruit immunosuppressive TAMs into the tumor, where they act to promote tumor progression through multiple mechanisms.

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin (2012) 62(1):10–2910.3322/caac.20138 - DOI - PubMed
    1. Morgan RJ, Jr, Alvarez RD, Armstrong DK, Boston B, Chen LM, Copeland L, et al. Ovarian cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2008) 6(8):766–94 - PubMed
    1. Winter WE, III, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol (2007) 25(24):3621–710.1200/JCO.2006.10.2517 - DOI - PubMed
    1. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med (2003) 348(3):203–1310.1056/NEJMoa020177 - DOI - PubMed
    1. Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol (2009) 22(3):393–40210.1038/modpathol.2008.191 - DOI - PubMed